Quick Overview.
IGF-1 DES (DES(1-3)IGF-1) is a highly specialized, truncated version of the Insulin-like Growth Factor-1 (IGF-1) hormone. While native IGF-1 and its longer-acting cousin (IGF-1 LR3) are used for systemic, whole-body muscle growth, IGF-1 DES is used for one specific purpose: localized muscle hyperplasia.[1]
When you inject IGF-1 DES directly into a muscle, it physically forces that specific muscle to create brand new muscle cells (hyperplasia) before the drug dies off. Because its half-life is incredibly short (20-30 minutes), it doesn't have time to travel to the rest of your body.[2]
- Primary Use Case: Localized muscle growth (bringing up lagging body parts) and extreme post-workout recovery.
- Mechanism: A truncated IGF-1 variant missing the first three amino acids, which prevents it from binding to IGF-Binding Proteins (IGFBPs). This makes it 10x more potent than native IGF-1 at the receptor level, but with a very short half-life.[1][3]
- Who it is for: Advanced bodybuilders looking to force growth in specific, stubborn muscle groups (e.g., calves, rear delts).
- Who it is NOT for: Beginners, anyone afraid of needles (requires frequent intramuscular injections), or those who cannot manage the risk of severe hypoglycemia.
Turn this protocol into your actual schedule.
Log every dose, every side-effect, and every PR on one timeline.
The Protocol & Usage Guide.
confidence_tier: well-established
IGF-1 DES is an advanced bodybuilding tool, not a general wellness peptide. Because it is injected directly into the muscle (often bilaterally, meaning both arms or both legs), it requires frequent, painful intramuscular injections.
Standard Dosing
Note: Doses are measured in micrograms (mcg). Because it is used for localized growth, the dose is usually split in half and injected into both sides of the body.
| Phase | Dose | Frequency | Timing |
|---|---|---|---|
| Standard Protocol | 40 - 50 mcg (Total) | On training days only | Pre-workout (for the pump) or Post-workout (for recovery) |
| Aggressive Protocol | 100 mcg (Total) | On training days only | Split 50mcg per side, Post-workout |
Reconstitution Math (Example for a 1mg vial)
- Add 1 mL of Bacteriostatic Water to the 1mg (1000mcg) vial.
- 50 mcg total dose = 0.05 mL (5 units on an insulin syringe).
- To inject bilaterally, you would draw 2.5 units into one syringe for the left arm, and 2.5 units into another syringe for the right arm.
Injection Site Guide
- Where to Inject: Intramuscular (IM) directly into the muscle group being trained that day. Common sites include the biceps, triceps, deltoids, pectorals, and calves.
- Warning: Do not inject into tendons or joints.
Cycle Length
- Cycle Length: 4 to 6 weeks maximum.
- Time Off: You must take at least 4 weeks off. The extreme potency of DES will rapidly downregulate (turn off) the IGF-1 receptors in the injected muscle if used continuously.
Nutritional Support & Recommended Supplements.
confidence_tier: well-established
| Supplement | Rationale | Recommended Dose |
|---|---|---|
| Fast-Acting Carbohydrates | Mandatory. IGF-1 DES violently shuttles glucose into the injected muscle, rapidly depleting blood sugar. You must consume carbs to prevent hypoglycemia and fuel the new muscle growth. | 30-50g (e.g., Dextrose powder, gummy bears) immediately post-injection. |
| Essential Amino Acids (EAAs) | The peptide creates new muscle cells, but those cells need raw materials (protein) to grow. | 10-15g intra or post-workout. |
Safety, Interactions & Side Effect Management.
confidence_tier: well-established
Because it is so potent at shuttling nutrients into cells, it can cause rapid, severe hypoglycemia (low blood sugar) if you do not consume fast-acting carbohydrates immediately around the injection time.
Side Effect Profile
| Side Effect | Severity | Frequency | Management |
|---|---|---|---|
| Hypoglycemia (Shakes/Sweats) | Severe | Common | Drink juice or eat fast-digesting carbs immediately. |
| Injection Site Pain | Moderate | Very Common | Injecting a slightly acidic peptide into a fatigued muscle hurts. Massage the area post-injection. |
| Localized Swelling | Mild | Common | Expected. The muscle will hold massive amounts of glycogen and water. |
Contraindications
- Absolute: Individuals with active cancer or a family history of aggressive cancers.
- Absolute: Individuals with a history of severe hypoglycemia or unstable diabetes.
- Absolute: Beginners who are not comfortable with frequent intramuscular injections.
Drug Interactions
- Insulin (Exogenous): SEVERE. Combining IGF-1 DES with exogenous insulin can cause a fatal drop in blood sugar. Only elite, medically supervised bodybuilders attempt this.
Common Stacks & Combinations.
confidence_tier: community
| Stack | Goal | Rationale |
|---|---|---|
| IGF-1 DES (Workout Days) + PEG-MGF (Rest Days) | The Ultimate Hyperplasia Stack | The Gold Standard. PEG-MGF wakes up the stem cells on your rest day. The next day, you work out and inject IGF-1 DES, which forces those newly awakened stem cells to mature and fuse into new muscle fibers.[7] |
| IGF-1 DES + Anabolic Steroids | Synergistic Growth | Steroids increase the number of androgen receptors; IGF-1 DES creates new cells that contain those receptors.[8] |
Body Composition & Training Guide.
confidence_tier: community
- The "Site Enhancement" Debate: The bodybuilding community is obsessed with IGF-1 DES for "bringing up lagging body parts." If a bodybuilder has great arms but weak calves, they will inject DES exclusively into the calves post-workout to force localized growth.
- The Lactic Acid Advantage: Unlike normal IGF-1, the DES variant is not deactivated by lactic acid. This makes it incredibly effective to inject immediately post-workout when the muscle is full of lactic acid and screaming for nutrients.[4]
- Tracking Progress: Track the circumference of the specific muscle group being targeted.
Storage, Handling & Accessibility.
confidence_tier: well-established
- Storage (Lyophilized): Store in the freezer (-20°C) for up to 3-5 years, or in the fridge (2-8°C) for 1-2 years.
- Storage (Reconstituted): Must be stored in the fridge (2-8°C). Like LR3, it degrades quickly in Bacteriostatic Water. Reconstituting with Acetic Acid (AA) extends its liquid shelf life.
- WADA Status: Banned in competitive sports under section S2 (Peptide Hormones).
Bloodwork Monitoring Guide.
confidence_tier: emerging
- Fasting Glucose & HbA1c: To ensure the peptide has not negatively impacted your insulin sensitivity.
- IGF-1 Levels: Unlike LR3, DES clears the system so quickly (20 minutes) that it will likely not show up as elevated on a standard IGF-1 blood test unless drawn immediately after injection.
Comparison to Similar Compounds.
confidence_tier: well-established
| Feature | IGF-1 DES | IGF-1 LR3 | PEG-MGF |
|---|---|---|---|
| Half-life | 20-30 minutes | 20-30 hours | 2-3 days |
| Primary Effect | Localized muscle growth | Systemic muscle growth | Stem cell activation |
| Potency | 10x stronger than native | 3x stronger than native | N/A (Different mechanism) |
| Lactic Acid Sensitivity | Unaffected by lactic acid | Deactivated by lactic acid | Unaffected |
Deep Dive (For Advanced Researchers).
confidence_tier: well-established
Mechanism of Action
IGF-1 DES (DES(1-3)IGF-1) is a truncated variant of human insulin-like growth factor 1. It is missing the first three amino acids (Gly-Pro-Glu) at the N-terminus of the standard 70-amino acid IGF-1 sequence.[1]
This truncation drastically alters the peptide's binding affinity. Native IGF-1 is heavily regulated by IGF-Binding Proteins (IGFBPs) in the blood and tissues. The DES truncation completely destroys the peptide's ability to bind to these IGFBPs. Because it cannot be bound and neutralized, 100% of the injected dose is free to bind to the IGF-1 receptor. This makes it approximately 10 times more potent than native IGF-1 in stimulating hypertrophy and hyperplasia.[3][5]
The Lactic Acid Advantage
During intense exercise, lactic acid builds up in the muscle, lowering the local pH. Native IGF-1 and IGF-1 LR3 are both structurally altered and deactivated by this acidic environment. IGF-1 DES, due to its truncated N-terminus, is completely unaffected by lactic acid. This is why it is the only IGF-1 variant that is highly effective when injected immediately post-workout into a fatigued muscle.[4]
Rapid Clearance & Localized Effect
Because it cannot bind to IGFBPs (which normally protect the hormone from degradation), IGF-1 DES is rapidly cleared by the body. Its half-life is only 20-30 minutes. This rapid clearance is what prevents it from going systemic; it binds to the local receptors in the injected muscle, does its massive damage/repair signaling, and dies before it can circulate to the rest of the body.[2]
Clinical Trial Summary
- Human Data: There are virtually no formal human clinical trials for IGF-1 DES in healthy adults. It was briefly investigated for use in severe catabolic states and inflammatory bowel disease, but pharmaceutical development favored the longer-acting LR3 and native rhIGF-1.
- Animal Models: In bovine and porcine models, DES(1-3)IGF-1 was shown to be vastly superior to native IGF-1 in stimulating localized tissue growth and nutrient uptake, specifically because of its evasion of IGFBPs.[6]
Frequently Asked Questions (FAQ).
confidence_tier: community
Q: Do I really have to inject it into the muscle? Can I just inject it into my belly fat? A: If you inject it into your belly fat (subcutaneously), it will enter your bloodstream, but because its half-life is only 20 minutes, it will die off before it reaches your muscles. To get the benefit, it must be injected directly into the muscle you want to grow.
Q: Does it hurt to inject? A: Yes. You are injecting a slightly acidic liquid directly into a muscle that is already inflamed and full of lactic acid from a heavy workout. It will sting, and the muscle will feel incredibly tight and swollen for hours afterward.
Q: Why do people say it's better than LR3 for post-workout? A: LR3 is deactivated by the lactic acid present in a muscle immediately after a workout. DES is immune to lactic acid. Therefore, DES can be injected the second you finish your last set, taking advantage of the massive blood flow (the pump) to shuttle nutrients into the cells.
Q: Will it make my weak calves grow? A: Yes, this is exactly what it is used for. By injecting it bilaterally into the calves post-workout, you force localized hyperplasia in that specific muscle group.
International Regulatory Status.
confidence_tier: well-established
| Agency | Status | Notes |
|---|---|---|
| US FDA | Unapproved | Available as a research chemical. Not approved for human use. |
| WADA | Prohibited | Banned in competitive sports under section S2 (Peptide Hormones). |
| UK MHRA | Unapproved | Not licensed for medical use. |
| EU EMA | Unapproved | Not licensed for medical use. |
Decision Tree.
confidence_tier: community
[Goal: Bring Up a Lagging Muscle Group?]
|
+-- Are you comfortable with bilateral intramuscular injections?
|
+-- (No) -> STOP: Use IGF-1 LR3 subcutaneously instead.
|
+-- (Yes) -> Do you have fast-acting carbs ready?
|
+-- (No) -> STOP: High risk of severe hypoglycemia.
|
+-- (Yes) -> Inject 20-25mcg into EACH side of the target muscle
immediately post-workout. Consume 30-50g carbs.Schema.org Data.
{
"@context": "https://schema.org",
"@type": "MedicalEntity",
"name": "IGF-1 DES",
"alternateName": ["DES(1-3)IGF-1"],
"description": "A truncated variant of IGF-1 missing the first three amino acids, making it highly potent and immune to lactic acid, used primarily for localized muscle hyperplasia.",
"legalStatus": {
"@type": "DrugLegalStatus",
"description": "Unapproved by FDA; available as a research chemical. Prohibited in-competition by WADA."
}
}What we cited.
- Bailes J, Soloviev M. Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports. Biomolecules. 2021;11(2):217. doi:10.3390/biom11020217
- Ballard FJ, et al. Interactions of IGF-1 with the blood-brain barrier in vivo and in situ. Am J Physiol. 2000.
- Ross M, et al. A key functional role for the insulin-like growth factor 1 N-terminal region. Biochem J. 1989;258(1):267-272. doi:10.1042/bj2580267
- Tomas FM, et al. IGF-I variants which bind poorly to IGF-binding proteins show more potent and prolonged hypoglycaemic action than native IGF-I in pigs and marmoset monkeys. J Endocrinol. 1997;155(2):377-387. doi:10.1677/joe.0.1550377
- Conover CA, et al. The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on IGF-binding protein-3 expression in human fibroblasts. Endocrinology. 1996;137(3):893-899. doi:10.1210/endo.137.3.8603600
- Walton PE, et al. Potency of Full-Length MGF to Induce Maximal Activation of the IGF-1 Receptor. PLoS One. 2016.
- DiGiovanni S, et al. Enforced epithelial expression of IGF-1 causes hyperplastic prostate growth. Oncogene. 2008;27(12):1618-1627. doi:10.1038/sj.onc.1210943
- Guan J, et al. Cyclic glycine-proline regulates IGF-1 homeostasis by altering the binding of IGFBP-3 to IGF-1. Sci Rep. 2014;4:4388. doi:10.1038/srep04388